P. Kramer

629 total citations
22 papers, 490 citations indexed

About

P. Kramer is a scholar working on Epidemiology, Infectious Diseases and Nephrology. According to data from OpenAlex, P. Kramer has authored 22 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Nephrology. Recurrent topics in P. Kramer's work include Renal Transplantation Outcomes and Treatments (5 papers), Influenza Virus Research Studies (4 papers) and Renal Diseases and Glomerulopathies (4 papers). P. Kramer is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Influenza Virus Research Studies (4 papers) and Renal Diseases and Glomerulopathies (4 papers). P. Kramer collaborates with scholars based in Netherlands, Germany and Gabon. P. Kramer's co-authors include Willem Weimar, Johannes Jeekel, Robert Zietse, Fibo W.J. ten Kate, A.B. Bijnen, N. Masurel, W.E.P. Beyer, Dennis Versluis, Maarten A.D.H. Schalekamp and P. J. H. Smak Gregoor and has published in prestigious journals such as The Lancet, Cancer and Transplantation.

In The Last Decade

P. Kramer

22 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Kramer Netherlands 12 213 151 136 96 70 22 490
F.M. González-Roncero Spain 11 126 0.6× 95 0.6× 196 1.4× 56 0.6× 58 0.8× 31 384
Matthew Edey United Kingdom 10 123 0.6× 258 1.7× 72 0.5× 84 0.9× 330 4.7× 15 668
A Duboust France 14 102 0.5× 142 0.9× 359 2.6× 93 1.0× 160 2.3× 45 763
First Mr United States 12 182 0.9× 32 0.2× 197 1.4× 36 0.4× 56 0.8× 46 569
M.R.N. Nampoory Kuwait 16 273 1.3× 118 0.8× 140 1.0× 16 0.2× 54 0.8× 49 692
S. Jirasiritham Thailand 11 194 0.9× 41 0.3× 164 1.2× 31 0.3× 29 0.4× 37 437
C. Schönemann Germany 11 159 0.7× 124 0.8× 471 3.5× 48 0.5× 205 2.9× 31 658
Hamid Shidban United States 8 133 0.6× 62 0.4× 367 2.7× 73 0.8× 25 0.4× 13 590
Pradeep V. Kadambi United States 13 95 0.4× 150 1.0× 217 1.6× 17 0.2× 66 0.9× 26 657
Richard Rohrer United States 11 291 1.4× 37 0.2× 229 1.7× 55 0.6× 21 0.3× 20 611

Countries citing papers authored by P. Kramer

Since Specialization
Citations

This map shows the geographic impact of P. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Kramer more than expected).

Fields of papers citing papers by P. Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Kramer. The network helps show where P. Kramer may publish in the future.

Co-authorship network of co-authors of P. Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Kramer. A scholar is included among the top collaborators of P. Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Kramer. P. Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kramer, P., et al.. (2012). Dihydrotestosterone treatment in mice induces a persistent polycystic ovary syndrome phenotype. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations
2.
Zietse, Robert, et al.. (2001). Immunosuppression should be stopped in patients with renal allograft failure. Clinical Transplantation. 15(6). 397–401. 89 indexed citations
3.
Bommel, Eric F.H. van, et al.. (1998). Progressive lipodystrophy, a diagnosis at a glance.. Nephrology Dialysis Transplantation. 13(2). 507–509. 3 indexed citations
4.
Gregoor, P. J. H. Smak, P. Kramer, Willem Weimar, & Jan L.C.M. van Saase. (1997). INFECTIONS AFTER RENAL ALLOGRAFT FAILURE IN PATIENTS WITH OR WITHOUT LOW-DOSE MAINTENANCE IMMUNOSUPPRESSION1. Transplantation. 63(10). 1528–1530. 40 indexed citations
5.
Gregoor, P. J. H. Smak, et al.. (1996). Disseminated histoplasmosis in a haemodialysis patient on immunosuppression after graft failure. Nephrology Dialysis Transplantation. 11(3). 542–544. 9 indexed citations
6.
Zietse, Robert, G J Wenting, P. Kramer, Maarten A.D.H. Schalekamp, & Willem Weimar. (1992). Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clinical Science. 82(6). 641–650. 52 indexed citations
7.
Bommel, Eric F.H. van, et al.. (1991). Haemophilus influenzae vertebral osteomyelitis in an adult. Acta Orthopaedica Scandinavica. 62(5). 493–494. 6 indexed citations
8.
Kramer, P., et al.. (1990). Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma‐derived vaccine with and without pre‐S2 antigen. European Journal of Clinical Investigation. 20(5). 540–545. 11 indexed citations
9.
Beyer, W.E.P., et al.. (1990). Effect of Immunomodulator Thymopentin on Impaired Seroresponse to Influenza Vaccine in Patients on Haemodialysis. ˜The œNephron journals/Nephron journals. 54(4). 296–301. 15 indexed citations
10.
Kramer, P., et al.. (1990). Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma‐derived vaccine with and without pre‐S2 antigen. European Journal of Clinical Investigation. 20(s1). 540–545. 9 indexed citations
11.
Versluis, Dennis, et al.. (1988). Intact Humoral Immune Response in Patients on Continuous Ambulatory Peritoneal Dialysis. ˜The œNephron journals/Nephron journals. 49(1). 16–19. 17 indexed citations
12.
Zietse, Robert, G J Wenting, P. Kramer, Maarten A.D.H. Schalekamp, & W. Weimar. (1988). Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndrome.. PubMed. 20(3 Suppl 4). 280–4. 6 indexed citations
13.
Versluis, Dennis, et al.. (1987). Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis.. BMJ. 294(6568). 348–348. 24 indexed citations
15.
Weimar, W, et al.. (1985). The incidence of cytomegalo- and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: a controlled study.. PubMed. 92. 37–9. 14 indexed citations
16.
Metselaar, Herold J., P. Kramer, A.B. Bijnen, et al.. (1985). Cytomegalovirus infections in renal transplant recipients. Correlation between clinical disease and results of a specific Elisa. Antiviral Research. 5. 127–130. 4 indexed citations
17.
Kramer, P., et al.. (1985). Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 55(3). 503–509. 11 indexed citations
18.
Kramer, P., A.B. Bijnen, Fibo W.J. ten Kate, Johannes Jeekel, & Willem Weimar. (1984). RECOMBINANT LEUCOCYTE INTERFERON A INDUCES STEROID-RESISTANT ACUTE VASCULAR REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTS. The Lancet. 323(8384). 989–990. 98 indexed citations
19.
Weimar, Willem, et al.. (1983). EFFECT OF INTERFERON ON QA-1 EXPRESSION. Transplantation. 36(3). 354–354. 1 indexed citations
20.
Lankisch, P. G., et al.. (1973). Use of Tenckhoff Catheter for Peritoneal Dialysis in Terminal Renal Failure. BMJ. 4(5894). 712–713. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026